Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis

被引：0

作者：

Silverberg, Jonathan, I ^{[1
]}

Bieber, Thomas ^{[2
,3
]}

Paller, Amy ^{[4
]}

Beck, Lisa A. ^{[5
]}

Kamata, Masahiro ^{[6
]}

Puig, Luis ^{[7
]}

Wiseman, Marni ^{[8
,9
]}

Ezzedine, Khaled ^{[10
]}

Foley, Peter ^{[11
]}

Johansson, Erin ^{[12
]}

Dossenbach, Martin ^{[12
]}

Akmaz, Bulent ^{[13
]}

Casillas, Marta ^{[12
]}

Karlsson, Andrei ^{[14
]}

Chovatiya, Raj ^{[15
]}

机构：

[1] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA

[2] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany

[3] Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland

[4] Northwestern Univ, Dept Dermatol, Chicago, IL USA

[5] Univ Rochester, Med Ctr, Rochester, NY USA

[6] Teikyo Univ, Sch Med, Dept Dermatol, Tokyo, Japan

[7] Hosp Santa Creu & Sant Pau, Dept Dermatol, Barcelona, Spain

[8] Univ Manitoba, Sect Dermatol, Winnipeg, MB, Canada

[9] SKiNWISE Dermatol, Winnipeg, MB, Canada

[10] Univ Paris Est, EpiDermE, Paris, France

[11] Skin Hlth Inst, Melbourne, Vic, Australia

[12] Eli Lilly & Co, Indianapolis, IN USA

[13] Almirall SA, Barcelona, Spain

[14] Costello Med, London, England

[15] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷

关键词：

atopic dermatitis; lebrikizumab; network meta-analysis; targeted systemic therapy;

D O I：

10.1093/bjd/ljae266.014

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

630

引用

页码：15 / 16

页数：2

共 50 条

[1] Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
Silverberg, Jonathan I.
Bieber, Thomas
Paller, Amy S.
Beck, Lisa
Kamata, Masahiro
Puig, Luis
Wiseman, Marni
Ezzedine, Khaled
Irvine, Alan D.
Foley, Peter
Del Rosso, James
Gold, Linda Stein
Johansson, Erin
Dossenbach, Martin
Gallo, Gaia
Akmaz, Buelent
Casillas, Marta
Karlsson, Andrei
Curteis, Tristan
Chovatiya, Raj
DERMATOLOGY AND THERAPY, 2025, 15 (03) : 615 - 633
[2] Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis
Lin, Jinger
Luo, Min
Zhuo, Qianwei
Chen, Nuo
Zhang, Haosong
Han, Yue
FRONTIERS IN PHARMACOLOGY, 2024, 15
[3] Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Smith, Brandon I.
Engel, Priya
Wu, Jashin
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2299 - 2300
[4] The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Bashrahil, Bader
Alzahrani, Ziyad
Samarkandy, Sahal
Aman, Abdullah
Jfri, Abdulhadi
FRONTIERS IN MEDICINE, 2023, 9
[5] Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis
Jonathan I. Silverberg
H. Chih-ho Hong
Brian M. Calimlim
Wan-Ju Lee
Henrique D. Teixeira
Eric B. Collins
Marjorie M. Crowell
Scott J. Johnson
April W. Armstrong
Dermatology and Therapy, 2023, 13 : 2247 - 2264
[6] Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis
Silverberg, Jonathan, I
Hong, H. Chih-ho
Calimlim, Brian M.
Lee, Wan-Ju
Teixeira, Henrique D.
Collins, Eric B.
Crowell, Marjorie M.
Johnson, Scott J.
Armstrong, April W.
DERMATOLOGY AND THERAPY, 2023, 13 (10) : 2247 - 2264
[7] Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis
Silverberg, Jonathan, I
Hong, H. Chih-ho
Thyssen, Jacob P.
Calimlim, Brian M.
Lee, Wan-Ju
Teixeira, Henrique D.
Collins, Eric B.
Crowell, Marjorie M.
Johnson, Scott J.
Armstrong, April W.
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[8] Comparative efficacy of targeted systemic therapies for pruritus in moderate-to-severe atopic dermatitis without topical treatment: a network meta-analysis
Xiong, Mei
Gao, Qiaoli
Ren, Hu
Zhong, Tingting
JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
[9] Comparison of efficacy of targeted therapies without topical corticosteroids for moderate-to-severe atopic dermatitis: systematic review and network meta-analysis
Silverberg, J. I.
Hong, H. C.
Thyssen, J. P.
Calimlim, B. M.
Joshi, A. D.
Teixeira, H. D.
Collins, E. B.
Crowell, M. M.
Johnson, S. J.
Armstrong, A. W.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E130 - E131
[10] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
Diana Bernardo
Thomas Bieber
Tiago Torres
American Journal of Clinical Dermatology, 2023, 24 : 753 - 764

← 1 2 3 4 5 →